Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ablished under a power-sharing deal between the military officers and civilians who have been running Sudan jointly since the overthrow of autocrat Omar al-Bashir in 2019." The AP (10/22, Federman, Magdy) reports that on Thursday, Sudanese officials "confirmed...that a senior U.S.-Israeli delegation flew to S

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

tablished under a power-sharing deal between the military officers and civilians who have been running Sudan jointly since the overthrow of autocrat Omar al-Bashir in 2019." The AP <https://r.bulletinintelligence.com/6628a600bac84c139da46fb64cc2c973> (10/22, Federman, Magdy) reports that on Thursday, Sudanese

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ablished under a power- sharing deal between the military officers and civilians who have been running Sudan jointly since the overthrow of autocrat Omar al-Bashir in 2019." The AP (10/22, Federman, Magdy) reports that on Thursday, Sudanese officials "confirmed...that a senior U.S.-Israeli delegation flew to S